2,488
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Improving drug prescription in general practice using a novel quality improvement model

, , , &
Pages 174-183 | Received 03 Jul 2020, Accepted 29 Jan 2021, Published online: 26 Jun 2021

References

  • The Health foundation (UK). Evidence scan: Levels of harm in primary care (Report). https://www.health.org.uk/sites/default/files/LevelsOfHarmInPrimaryCare.pdf November 2011.
  • de Wet C, Bowie P. The preliminary development and testing of a global trigger tool to detect error and patient harm in primary-care records. Postgrad Med J. 2009;85(1002):176–180.
  • Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–1259.
  • Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–396.
  • Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42(7):1017–1025.
  • Davies EA, O’Mahony MS. Adverse drug reactions in special populations - the elderly. Br J Clin Pharmacol. 2015;80(4):796–807.
  • Cullinan S, Raae Hansen C, Byrne S, et al. Challenges of deprescribing in the multimorbid patient. Eur J Hosp Pharm. 2017;24(1):43–46.
  • Gillespie RJ, Harrison L, Mullan J. Deprescribing medications for older adults in the primary care context: a mixed studies review. Health Sci Rep. 2018;1(7):e45.
  • Vaismoradi M, Logan PA, Jordan S, et al. Adverse drug reactions in norway: a systematic review. Pharmacy. 2019;7(3):102.
  • Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–2724.
  • O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218.
  • Rognstad S, Brekke M, Fetveit A, et al. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care. 2009;27(3):153–159.
  • Clyne B, Smith SM, Hughes CM, et al. Effectiveness of a multifaceted intervention for potentially inappropriate prescribing in older patients in primary care: a cluster-randomized controlled trial (OPTI-SCRIPT Study). Ann Fam Med. 2015;13(6):545–553.
  • Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845–854.
  • Romskaug R, Skovlund E, Straand J, et al. Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients receiving polypharmacy: a cluster randomized clinical trial. JAMA Intern Med. 2020;180(2):181–189.
  • Dreischulte T, Donnan P, Grant A, et al. Safer prescribing–a trial of education, informatics, and financial incentives. N Engl J Med. 2016;374(11):1053–1064.
  • Leendertse AJ, de Koning GH, Goudswaard AN, et al. Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population. J Clin Pharm Ther. 2013;38(5):379–387.
  • Olsen KR, Anell A, Häkkinen U, et al. General practice in the Nordic countries. Nordic J Health Eco. 2016;4(1):56–67.
  • Kilo CM. A framework for collaborative improvement: lessons from the Institute for Healthcare Improvement’s breakthrough series. Qual Manag Health Care. 1998;6(4):1–13.
  • Øvretveit J, Bate P, Cleary P, et al. Quality collaboratives: lessons from research. Qual Saf Health Care. 2002;11(4):345–351.
  • Lennox L, Maher L, Reed J. Navigating the sustainability landscape: a systematic review of sustainability approaches in healthcare. Implement Sci. 2018;13(1):27.
  • Kellogg KC, Gainer LA, Allen AS, et al. An intraorganizational model for developing and spreading quality improvement innovations. Health Care Manage Rev. 2017;42(4):292–302.
  • Wells S, Tamir O, Gray J, et al. Are quality improvement collaboratives effective? A systematic review. BMJ Qual Saf. 2018;27(3):226–240.
  • Franx G, Huyser J, Koetsenruijter J, et al. Implementing guidelines for depression on antidepressant prescribing in general practice: a quasi-experimental evaluation. BMC Fam Pract. 2014;15:35.
  • Rognstad S, Brekke M, Fetveit A, et al. Prescription peer academic detailing to reduce inappropriate prescribing for older patients: a cluster randomised controlled trial. Br J Gen Pract. 2013;63(613):e554–e562.
  • Spehar I, Sjovik H, Karevold KI, et al. General practitioners’ views on leadership roles and challenges in primary health care: a qualitative study. Scand J Prim Health Care. 2017;35(1):105–110.
  • Langley GJ, Moen RD, Nolan TW, et al. The model for improvement. In Provost PL, Norman CL, Moen RD, Nolan TW, editors. The improvement guide: a practical approach to enhancing organizational performance. 2nd ed. San Fransisco (CA): John Wiley and Sons; 2009. p. 23–25.
  • Perla RJ, Provost LP, Murray SK. The run chart: a simple analytical tool for learning from variation in healthcare processes. BMJ Qual Saf. 2011;20(1):46–51.
  • Sunde M, Nygaard MM, Hoye S. General practitioners’ attitudes toward municipal initiatives to improve antibiotic prescribing-a mixed-methods study. Antibiotics. 2019;8(3):120.
  • Høye S, Braend AM, Spehar I. Quality improvement and antimicrobial stewardship in general practice - the role of the municipality chief medical officer. A qualitative study. Scand J Prim Health Care. 2020;38(3):352–359.
  • Wiltsey Stirman S, Kimberly J, Cook N, et al. The sustainability of new programs and innovations: a review of the empirical literature and recommendations for future research. Implement Sci. 2012;7:17.